London-based space biotech startup, Mass Balance, launched its first mission into space on Tuesday on a SpaceX Falcon 9 ...
The Boston-based drugmaker has been on a mission to build out the next generation of drug products beyond its cystic fibrosis ...
July 7 (Reuters) - Obesity-focused clinical-stage biotechnology company Kalohexis on Tuesday confidentially filed to go public in the U.S., adding to an activity rebound in the initial public offering ...
Vertex Pharmaceuticals is buying an endocrine treatment specialist for $10 billion.
The tuition-free program trained unemployed and under-employed Maryland residents for careers in biotechnology and biomedical ...
On CNBC’s Mad Dash segment on Monday, July 6, 2026, Jim Cramer made one of his most bullish biotech calls in years, arguing ...
Explore advancements in biotechnology, from gene editing's ethical dilemmas to synthetic biology's commercial potential and ...
Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...
Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO, whilst ...
LG Chem said Wednesday it has signed a strategic partnership with Shanghai-based OTR Therapeutics to identify and develop ...
United Therapeutics, a biotechnology company with co-headquarters and manufacturing facilities in Research Triangle Park, has acquired a Boston-area biotech company to boost its efforts in ...
As U.S. lawmakers continue to scrutinize the consequences of China’s expanding role in biotech innovation, industry insiders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results